Early research (Phase 1)WithdrawnNCT01197209What this trial is testingNeoadjuvant Study of In-situ REIC/Dkk-3 in Prostate CancerWho this might be right forProstate Cancer Momotaro-Gene Inc.
Early research (Phase 1)Study completedNCT02111187What this trial is testingA Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate CancerWho this might be right forProstate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 14
Testing effectiveness (Phase 2)Looking for participantsNCT06085664What this trial is testingA Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical ProstatectomyWho this might be right forProstate CancerRadical Prostatectomy M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT00022412What this trial is testingDoxercalciferol Before Surgery in Treating Localized Prostate CancerWho this might be right forProstate Cancer University of Wisconsin, Madison 60
Large-scale testing (Phase 3)Looking for participantsNCT06625970What this trial is testingStudy Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of RelapseWho this might be right forHigh Risk Prostate CarcinomaProstate Cancer UNICANCER 700
Early research (Phase 1)Active Not RecruitingNCT06703437What this trial is testingLong Acting Neuraxial Peri-prostatic Block in CancerWho this might be right forProstate Cancer Icahn School of Medicine at Mount Sinai 12
Testing effectiveness (Phase 2)Looking for participantsNCT04812366What this trial is testingGenomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate CancerWho this might be right forProstate Cancer University of British Columbia 315
Not applicableStudy completedNCT01123434What this trial is testingImmediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.Who this might be right for2 Years PSA Recurrence Rate AstraZeneca 200
Not applicableLooking for participantsNCT06864533What this trial is testingAdjuvant Chemotherapy for High Malignant Prostate CancerWho this might be right forProstate CancerRadiation TherapyChemotherapy+1 more Peking University First Hospital 315
Large-scale testing (Phase 3)Study completedNCT00033631What this trial is testingRadiation Therapy in Treating Patients With Stage II Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 1,534
Testing effectiveness (Phase 2)Study completedNCT02107430What this trial is testingPhase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate CancerWho this might be right forProstate Cancer SOTIO a.s. 62
Not applicableLooking for participantsNCT06362577What this trial is testingClinical Study of HIFU for Localized Prostate CancerWho this might be right forLocalized Prostate Cancer RenJi Hospital 60
Testing effectiveness (Phase 2)Study completedNCT02874014What this trial is testingHypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate CancerWho this might be right forProstate Cancer Mayo Clinic 56
Testing effectiveness (Phase 2)Looking for participantsNCT06798558What this trial is testingNeoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical ProstatectomyWho this might be right forProstate Adenocarcinoma Hackensack Meridian Health 54
Testing effectiveness (Phase 2)Study completedNCT01250717What this trial is testingDocetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate CancerWho this might be right forProstate Cancer Beth Israel Deaconess Medical Center 28
Not applicableLooking for participantsNCT06389786What this trial is testingAccuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate CancerWho this might be right forLocalized Prostate CarcinomaOligometastatic Prostate CarcinomaStage I Prostate Cancer AJCC v8+3 more Mayo Clinic 50
Very early researchStudy completedNCT02420977What this trial is testingEvaluation of PSMA-based PET as an Imaging Biomarker in Prostate CancerWho this might be right forAdvanced Prostate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Large-scale testing (Phase 3)UnknownNCT01398657What this trial is testingCryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate CancerWho this might be right forProstate Cancer National Taiwan University Hospital 182
Testing effectiveness (Phase 2)Study completedNCT00225420What this trial is testingDocetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate CancerWho this might be right forProstate Cancer UNC Lineberger Comprehensive Cancer Center 23
Large-scale testing (Phase 3)Active Not RecruitingNCT01952223What this trial is testingA Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of RelapseWho this might be right forAdenocarcinoma of ProstateProgression of Prostate Cancer UNICANCER 761